Chromatography Forum of the Delaware Valley Dal Nogare Award - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Chromatography Forum of the Delaware Valley Dal Nogare Award


Meeting Reports

Session 230, Room 206A

The 2012 Chromatography Forum of the Delaware Valley Dal Nogare Award will be presented to Purnendu K. (Sandy) Dasgupta, professor of chemistry and biochemistry at the University of Texas at Arlington, this morning at Pittcon 2012. The award will be presented by Mary Ellen P. McNally of Dupont Crop Protection. The Chromatography Forum of the Delaware Valley chooses award recipients based on their contributions to the fundamental understanding of the chromatographic process. The award was established in honor of Stephen Dal Nogare, who died in 1968 after serving for six months as president of the Chromatography Forum. Dasgupta will be recognized for his work on the principles and applications of ion chromatography.

A session of oral presentations will follow, with talks to be given by Dasgupta on the development of electrodialytic devices in ion chromatography, Christopher Pohl (Thermo Fisher Scientific) on the synthesis of anion-exchange condensation polymers, Janusz Pawliszyn (University of Waterloo) on thin-film solid-phase microextraction, Daniel Armstrong (University of Texas at Arlington) on ionic liquids for chemical and biochemical analysis, and Kannan Srinivasan (Thermo Fisher Scientific) on advances in the charge detector concept for ion chromatography.

Dasgupta’s accomplishments include the development of electrodialytic suppressors, eluent generators, and postcolumn reagent introduction devices. Other research interests include the measurement of trace atmospheric species and atmospheric chemistry, 
air pollution toxicology
, automated intelligent analyzers
, microfabricated sensors and instrumentation, 
thin-film flow devices and sensors, automated process analyzers for the chemical industry, 
novel approaches to ionic analysis, breath gas measurement in disease diagnostics, perchlorate in the environment, and trace element nutrition.

Dasgupta has written more than 300 papers and book chapters, and holds 17 US patents, including the electrodialytic reagent generation and suppression technologies on which current ion chromatography is based. He has received a number of awards, including the Dow Chemical Company Traylor Creativity Award, the Ion Chromatography Symposium Outstanding Achievement Award (in 1989 and in 2005), the Benedetti-Pichler Memorial Award in microchemistry, the William J. Probst Lecturer Award, Achievement Rewards for College Scientists (ARCS) Scientist of the Year Award 2004-2005, and the Best Science Paper of the Year Award, Environmental Science and Technology, 2005. He is also the editor of the analytical chemistry journal Analytica Chimica Acta.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Meeting Reports,
Click here